Parotid lipomatosis in HIV positive patients: A new clinical disorder associated with protease inhibitors [3]

Annals of the Rheumatic Diseases

Volumn 57, Issue 12, 1998, Pages 749-

  Olivé, Alejandro ^a   Salavert, Agust́i ^b   Manríquez, Marcela ^b   Clotet, Bonaventura ^b   Moragas, August ^b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; CLINICAL FEATURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIPID STORAGE; LIPOMATOSIS; MALE; PRIORITY JOURNAL;

EID: 0345040697     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.12.749     Document Type: Letter

References (6)

1. Flexner CH. HIV-protease inhibitors. N Engl J Med 1998;338:1281-92.
2. Lipsky JJ. Abnormal fat accumulation in patients with HIV infection. Lancet 1998;351: 847-8.
3. Miller KD, Jones E, Yanovsky JA, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use on indinavir. Lancet 1998;351:871-5.
4. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. "Buffalo hump" in men with HIV-1 infection. Lancet 1998;351:867-70.
5. Schrot RJ, Adelman HM, Linden CN, Wallach PM. Cystic parotid gland enlargement in HIV disease. The diffuse infiltrative lymphocytosis syndrome. JAMA 1997;278:166-7.
6. Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 1908; 351:1881-3.